Clinical Trials Directory

Trials / Completed

CompletedNCT01310712

Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study

Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Video-assisted thoracic sympathectomy (VATS) provides excellent resolution of palmar and axillary hyperhidrosis but is associated with compensatory hyperhidrosis. Low doses of Oxybutynin can be used to treat palmar hyperhidrosis with fewer side effects.

Detailed description

Introduction: Video-assisted thoracic sympathectomy (VATS) provides excellent resolution of palmar and axillary hyperhidrosis but is associated with compensatory hyperhidrosis. Low doses of Oxybutynin can be used to treat palmar hyperhidrosis with fewer side effects. Purpose: The objective of this study is to evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses comparing to placebo for treating palmar hyperhidrosis. Methods: This is a prospective, randomized and controlled study. From December 2010 to february 2011, 50 consecutive patients with palmar hyperhidrosis were treated with oxybutynin or placebo. Data were collected from 50 patients, and 5 (10,0%) patients were lost to follow-up. During the first week, patients received 2.5 mg of oxybutynin once a day in the evening. From the 8th to the 42nd day, they received 2.5 mg twice a day, and from the 43rd day to the end of the 12th week, they received 5 mg twice a day. All of the patients underwent 2 evaluations: before and after (12 weeks) the oxybutynin treatment, using a clinical questionnaire; and a clinical protocol for quality of life (QOL).

Conditions

Interventions

TypeNameDescription
DRUGOxybutynin5 mg every 12 hours for 6 weeks
DRUGplaceboplacebo twice a day for 42 days.

Timeline

Start date
2010-12-01
Primary completion
2011-02-01
Completion
2011-03-01
First posted
2011-03-08
Last updated
2011-09-22

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01310712. Inclusion in this directory is not an endorsement.